Logo image of BV

BRIGHTVIEW HOLDINGS INC (BV) Stock Fundamental Analysis

NYSE:BV - New York Stock Exchange, Inc. - US10948C1071 - Common Stock

15.98  +0.19 (+1.2%)

After market: 15.98 0 (0%)

Fundamental Rating

4

Overall BV gets a fundamental rating of 4 out of 10. We evaluated BV against 83 industry peers in the Commercial Services & Supplies industry. BV scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BV is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

BV had positive earnings in the past year.
BV had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BV reported negative net income in multiple years.
In the past 5 years BV always reported a positive cash flow from operatings.
BV Yearly Net Income VS EBIT VS OCF VS FCFBV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

1.2 Ratios

BV has a Return On Assets (0.57%) which is comparable to the rest of the industry.
BV has a Return On Equity of 1.09%. This is comparable to the rest of the industry: BV outperforms 46.34% of its industry peers.
BV has a Return On Invested Capital (2.70%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for BV is significantly below the industry average of 10.10%.
The 3 year average ROIC (2.40%) for BV is below the current ROIC(2.70%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.57%
ROE 1.09%
ROIC 2.7%
ROA(3y)0.26%
ROA(5y)0.17%
ROE(3y)0.6%
ROE(5y)0.4%
ROIC(3y)2.4%
ROIC(5y)2.06%
BV Yearly ROA, ROE, ROICBV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4 -6

1.3 Margins

Looking at the Profit Margin, with a value of 0.70%, BV is in line with its industry, outperforming 43.90% of the companies in the same industry.
In the last couple of years the Profit Margin of BV has declined.
BV has a Operating Margin (4.09%) which is comparable to the rest of the industry.
BV's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 23.33%, BV is doing worse than 67.07% of the companies in the same industry.
In the last couple of years the Gross Margin of BV has declined.
Industry RankSector Rank
OM 4.09%
PM (TTM) 0.7%
GM 23.33%
OM growth 3Y4.93%
OM growth 5Y-5.36%
PM growth 3Y-27.02%
PM growth 5Y-17.52%
GM growth 3Y-2.9%
GM growth 5Y-2.54%
BV Yearly Profit, Operating, Gross MarginsBV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BV is destroying value.
The number of shares outstanding for BV has been increased compared to 1 year ago.
BV has less shares outstanding than it did 5 years ago.
BV has a better debt/assets ratio than last year.
BV Yearly Shares OutstandingBV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BV Yearly Total Debt VS Total AssetsBV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.54, we must say that BV is in the distress zone and has some risk of bankruptcy.
BV has a worse Altman-Z score (1.54) than 68.29% of its industry peers.
BV has a debt to FCF ratio of 6.31. This is a slightly negative value and a sign of low solvency as BV would need 6.31 years to pay back of all of its debts.
BV has a better Debt to FCF ratio (6.31) than 64.63% of its industry peers.
BV has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
BV has a Debt to Equity ratio (0.45) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 6.31
Altman-Z 1.54
ROIC/WACC0.32
WACC8.44%
BV Yearly LT Debt VS Equity VS FCFBV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

BV has a Current Ratio of 1.44. This is a normal value and indicates that BV is financially healthy and should not expect problems in meeting its short term obligations.
BV has a Current ratio of 1.44. This is comparable to the rest of the industry: BV outperforms 43.90% of its industry peers.
A Quick Ratio of 1.44 indicates that BV should not have too much problems paying its short term obligations.
BV's Quick ratio of 1.44 is fine compared to the rest of the industry. BV outperforms 60.98% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.44
BV Yearly Current Assets VS Current LiabilitesBV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.36% over the past year.
Measured over the past years, BV shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.19% on average per year.
BV shows a decrease in Revenue. In the last year, the revenue decreased by -1.74%.
Measured over the past years, BV shows a small growth in Revenue. The Revenue has been growing by 2.85% on average per year.
EPS 1Y (TTM)36.36%
EPS 3Y-14.5%
EPS 5Y-8.19%
EPS Q2Q%57.89%
Revenue 1Y (TTM)-1.74%
Revenue growth 3Y2.71%
Revenue growth 5Y2.85%
Sales Q2Q%-2.02%

3.2 Future

Based on estimates for the next years, BV will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.33% on average per year.
BV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.83% yearly.
EPS Next Y16.89%
EPS Next 2Y14.67%
EPS Next 3Y13.33%
EPS Next 5YN/A
Revenue Next Year1.09%
Revenue Next 2Y2.31%
Revenue Next 3Y2.83%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BV Yearly Revenue VS EstimatesBV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
BV Yearly EPS VS EstimatesBV Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

BV is valuated rather expensively with a Price/Earnings ratio of 21.31.
Compared to the rest of the industry, the Price/Earnings ratio of BV indicates a somewhat cheap valuation: BV is cheaper than 70.73% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.96. BV is valued slightly cheaper when compared to this.
BV is valuated rather expensively with a Price/Forward Earnings ratio of 18.23.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BV indicates a somewhat cheap valuation: BV is cheaper than 75.61% of the companies listed in the same industry.
BV's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.11.
Industry RankSector Rank
PE 21.31
Fwd PE 18.23
BV Price Earnings VS Forward Price EarningsBV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

71.95% of the companies in the same industry are more expensive than BV, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BV indicates a somewhat cheap valuation: BV is cheaper than 78.05% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.93
EV/EBITDA 8.4
BV Per share dataBV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as BV's earnings are expected to grow with 13.33% in the coming years.
PEG (NY)1.26
PEG (5Y)N/A
EPS Next 2Y14.67%
EPS Next 3Y13.33%

0

5. Dividend

5.1 Amount

BV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BRIGHTVIEW HOLDINGS INC

NYSE:BV (1/17/2025, 8:04:01 PM)

After market: 15.98 0 (0%)

15.98

+0.19 (+1.2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)02-06 2025-02-06/amc
Inst Owners69.34%
Inst Owner Change0.01%
Ins Owners2.71%
Ins Owner Change0.91%
Market Cap1.52B
Analysts81.11
Price Target18.92 (18.4%)
Short Float %7.05%
Short Ratio8.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.19
Dividend Growth(5Y)N/A
DP91.28%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.11%
Min EPS beat(2)-4.54%
Max EPS beat(2)-1.68%
EPS beat(4)1
Avg EPS beat(4)-1.4%
Min EPS beat(4)-50.72%
Max EPS beat(4)51.33%
EPS beat(8)4
Avg EPS beat(8)11%
EPS beat(12)5
Avg EPS beat(12)4.08%
EPS beat(16)7
Avg EPS beat(16)12.8%
Revenue beat(2)0
Avg Revenue beat(2)-2.39%
Min Revenue beat(2)-2.61%
Max Revenue beat(2)-2.17%
Revenue beat(4)0
Avg Revenue beat(4)-3.73%
Min Revenue beat(4)-5.68%
Max Revenue beat(4)-2.17%
Revenue beat(8)1
Avg Revenue beat(8)-2.64%
Revenue beat(12)2
Avg Revenue beat(12)-1.81%
Revenue beat(16)4
Avg Revenue beat(16)-0.77%
PT rev (1m)3.1%
PT rev (3m)8.81%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.13%
EPS NY rev (1m)0.72%
EPS NY rev (3m)-1.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.61%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)-0.42%
Valuation
Industry RankSector Rank
PE 21.31
Fwd PE 18.23
P/S 0.55
P/FCF 11.93
P/OCF 7.38
P/B 0.85
P/tB N/A
EV/EBITDA 8.4
EPS(TTM)0.75
EY4.69%
EPS(NY)0.88
Fwd EY5.49%
FCF(TTM)1.34
FCFY8.38%
OCF(TTM)2.16
OCFY13.54%
SpS29.13
BVpS18.76
TBVpS-3.46
PEG (NY)1.26
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.57%
ROE 1.09%
ROCE 3.98%
ROIC 2.7%
ROICexc 2.84%
ROICexgc 12.87%
OM 4.09%
PM (TTM) 0.7%
GM 23.33%
FCFM 4.6%
ROA(3y)0.26%
ROA(5y)0.17%
ROE(3y)0.6%
ROE(5y)0.4%
ROIC(3y)2.4%
ROIC(5y)2.06%
ROICexc(3y)2.47%
ROICexc(5y)2.14%
ROICexgc(3y)10.98%
ROICexgc(5y)10.41%
ROCE(3y)3.54%
ROCE(5y)3.05%
ROICexcg growth 3Y-0.5%
ROICexcg growth 5Y-6.24%
ROICexc growth 3Y6.57%
ROICexc growth 5Y-3.78%
OM growth 3Y4.93%
OM growth 5Y-5.36%
PM growth 3Y-27.02%
PM growth 5Y-17.52%
GM growth 3Y-2.9%
GM growth 5Y-2.54%
F-Score6
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 6.31
Debt/EBITDA 3.12
Cap/Depr 54.37%
Cap/Sales 2.83%
Interest Coverage 1.67
Cash Conversion 79.84%
Profit Quality 652.31%
Current Ratio 1.44
Quick Ratio 1.44
Altman-Z 1.54
F-Score6
WACC8.44%
ROIC/WACC0.32
Cap/Depr(3y)57.78%
Cap/Depr(5y)51.34%
Cap/Sales(3y)3.08%
Cap/Sales(5y)2.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.36%
EPS 3Y-14.5%
EPS 5Y-8.19%
EPS Q2Q%57.89%
EPS Next Y16.89%
EPS Next 2Y14.67%
EPS Next 3Y13.33%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.74%
Revenue growth 3Y2.71%
Revenue growth 5Y2.85%
Sales Q2Q%-2.02%
Revenue Next Year1.09%
Revenue Next 2Y2.31%
Revenue Next 3Y2.83%
Revenue Next 5YN/A
EBIT growth 1Y12.07%
EBIT growth 3Y7.78%
EBIT growth 5Y-2.67%
EBIT Next Year74.51%
EBIT Next 3Y25.87%
EBIT Next 5YN/A
FCF growth 1Y117.07%
FCF growth 3Y13.41%
FCF growth 5Y9.77%
OCF growth 1Y58.28%
OCF growth 3Y11.48%
OCF growth 5Y3.91%